Or Filter by:

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA

1-877-ELANCO1

(1-877-352-6261)

Media Contacts

Questions?
Contact us.



Our Global Offices

Follow Elanco

30-Jan-2019

Elanco Revises Date for Fourth Quarter 2018 Financial Results

Post by: Colleen Parr Dekker

GREENFIELD, Ind. (January 30, 2019)– Elanco Animal Health (NYSE: ELAN) has revised the date for its fourth-quarter and full-year 2018 financial results announcement. The company will now announce results on Wednesday, Feb. 6, 2019, one week earlier than previously scheduled. Elanco will also conduct a conference call with the investment community and media on that day to further detail the company's financial performance.

The conference call will begin at 8:00 a.m. Eastern time. Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Elanco’s website at https://investor.elanco.com/investors/events-and-presentations/events-calendar/default.aspx. A replay will also be available on the website following the conference call.

About Elanco
Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for approximately 5,700 employees. At Elanco, we’re driven by our vision of food and companionship enriching life - all to advance the health of animals, people and the planet. Learn more at www.elanco.com.

Investors Contact:
Jim Greffet
(317) 383-9935
greffet_james_f@elanco.com

Media Contact:
Colleen Parr Dekker
(317) 276-4076
parr_dekker_colleen@elanco.com

General Inquiries

Elanco Animal Health
2500 Innovation Way
Greenfield, IN 46140 USA

1-877-ELANCO1

(1-877-352-6261)

Media Contacts

Questions?
Contact us.



Our Global Offices

Follow Elanco

About Elanco

Elanco (NYSE: ELAN) is a global animal health company that develops products and knowledge services to prevent and treat disease in food animals and pets in more than 90 countries. With a 64-year heritage, we rigorously innovate to improve the health of animals and benefit our customers, while fostering an inclusive, cause-driven culture for more than 5,800 employees. At Elanco, we’re driven by our vision of food and companionship enriching life – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.